Foundation Medicine
Healthcare & Life Sci
Company overview
Foundation Medicine is a precision medicine company that specializes in genomic testing and diagnostic solutions, primarily for cancer care. FoundationOne CDx is a tissue-based comprehensive genomic profiling test. FoundationOne Liquid CDx is the blood-based version. FoundationOne Heme profiles hematologic malignancies, and FoundationOne RNA handles RNA profiling.
The company was founded in 2010 in Cambridge, Massachusetts, and is now headquartered in Boston. It went public in 2013 on Nasdaq under the ticker FMI, then became a private subsidiary of Roche, which completed its acquisition in 2018. Foundation Medicine employs approximately 1,700 people worldwide and has delivered over 1.5 million patient comprehensive genomic profiling reports.
Currently, there are no job openings at Foundation Medicine. Over the last 30 days, 0 jobs were added and 0 were removed. Foundation Medicine is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Cambridge, United States